Funding
Ongoing Research Support
1R15NS121784 Kim (PI) 12/01/21 - 11/30/24 NIH. Prevention of alpha-synuclein deSUMOylation as a Parkinson’s therapeutic target.
5T32GM144895 Harrington & Kim (PIs) 05/01/22 – 4/30/27 NIH-G-RISE. Diversifying Neuroscience through predoctoral training at an HBCU.
1R25GM122722 Kim & Harrington (PIs) 05/01/17 - 03/31/23 (NCE) NIH-RISE. A graduate training program to increase diversity in biomedical Science.
Private Fund Kim (PI) 02/01/19 - 12/31/22 AptaBio therapeutics Inc. Developing a novel antioxidant compound as a therapeutic for Parkinson’s disease.
Copyright © 2022 Kim Lab for Neurodegenerative and Senescence Research - All Rights Reserved.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
